Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Rosuvastatin for Reduction of Postoperative Paroxysmal Atrial Fibrillation in Patient Undergoing Radiofrequency Catheter Ablation

NCT02502110 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.

NCT NCT02502110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02502110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Rosuvastatin for Reduction of Postoperative Paroxysmal Atrial Fibrillation in Patient Undergoing Radiofrequency Catheter Ablation
Lead sponsor
The Third Xiangya Hospital of Central South University
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2015
Completion date
June 30, 2019
Enrollment
346 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation